Prospective designing and types of buccal drug delivery system: The Review
1 Student of Master of Pharmacy, department of Pharmaceutics, S.G.S.P.S. Institute of Pharmacy, Khulkhed, Akola, (MH), India.444002.
2 Faculty in department of Pharmaceutics, S.G.S.P.S. Institute of Pharmacy, Khulkhed, Akola, (MH), India.444002.
3 Principal, S.G.S.P.S. Institute of Pharmacy, Khulkhed, Akola, (MH), India.444002.
Review Article
GSC Biological and Pharmaceutical Sciences, 2020, 12(03), 174-179.
Article DOI: 10.30574/gscbps.2020.12.3.0298
Publication history:
Received on 16 September 2020; revised on 22 September 2020; accepted on 25 September 2020
Abstract:
Buccal bioadhesive films, releasing topical drugs in the oral cavity at a slow and predetermined rate, provide distinct advantages over traditional dosage forms for treatment of many diseases. The mucosa of the buccal cavity is the most easily accessible transmucosal site. This fast dissolving drug delivery system (FDDS) is suited for the drugs which undergo high first pass metabolism and is used for improving bioavailability with reducing dosing frequency to mouth plasma peak levels, which in turn minimize adverse/side effects and also make it cost effective This article aims to review the recent Designs of buccal patches and their developments in the buccal adhesive drug delivery systems, & Buccal drug delivery is a promising area for continued research with the aim of systemic delivery of orally inefficient drugs as well as a feasible and attractive alternative for non-invasive delivery of potent peptide and protein drug molecules.
Keywords:
Bioadhesive film; Bioavailability; Buccal patches.
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
